A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI
Clinical trial NCT02370537 · COMPLETED
Trial details
- NCT number
- NCT02370537
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2015-11-01
- Enrollment
- 490
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.